Contrast induced nephropathy

Farmacia

Volumn 57, Issue 1, 2009, Pages 5-16

  Caldararu, Carmen ^a   Chritopher, Kenneth ^b   Dogaru, Maria ^a   Dogaru, Grigore ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute renal failure; Contrast induced nephropathy; Contrast media

Indexed keywords

ACETYLCYSTEINE; ATRIAL NATRIURETIC FACTOR; BICARBONATE; CONTRAST MEDIUM; DOPAMINE; FENOLDOPAM; IODINATED CONTRAST MEDIUM; PROSTAGLANDIN E1; SODIUM CHLORIDE; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG INDUCED DISEASE; HEMODIALYSIS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; HYDRATION; INCIDENCE; KIDNEY DISEASE; NEPHROTOXICITY; PATHOPHYSIOLOGY; PROTEINURIA; RISK FACTOR; SIDE EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; VASODILATATION;

EID: 62649130686     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Conti RM - Contrast nephropathy or contrast creatininopathy, Clin. Cardiol., 2003, 26: 53-54
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936
3. Mehran R, Nikolsky E - Contrast-induced nephropathy: Definition,epidemiology, and patients at risk, Kidney International, 2006, 69: S11-S15
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: modification of diet in renal disease study group. Ann Intern Med 1999;130:461-470
5. Lepor NE, Mathur VS - Radiocontrast nephropathy. Current Interventional Cardiology Reports, 2000, 2: 335-341
6. Waybill MM, Waybill PN - Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J.Vasc.Interv.Radiol., 2001, 12: 3-9
7. Murphy SW, Barrett BJ, Parfrey PS - Contrast nephropathy J.Am.Soc.Nephrol., 2000, 11: 177-182
8. Rihal CJ, Textor SC, Grill DE et al - Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002, 105: 2259-2264
9. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW - Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997, 103: 368-375
10. Persson PB, Tepel M - Contrast medium-induced nephropathy: The pathophysiology, Kidney International 2006, 69, S8-S10
11. Maeder M, Klein M, Fehr T, Rickli H - Contrast nephropathy: review focusing on prevention. J AmColl Cardiol. 2004; 44:1763-1771
12. Cox CG, Tsikouris JP - Preventing contrast nephropathy: what is the best strategy? A review of the literature.'' J. Clin. Pharmacol. 2004, 44: 327-337
13. McCullough PA, Bertrand ME, Brinker JA, Stacul F - A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media, J.Am.Coll.Cardiol, 2006, 48: 694-699
14. Solomon RJ, Natarajan MK, Doucet S et al - Cardiac Angiography in Renally Impaired Patients (CARE) Study. A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation, 2007, 115: 3189-96
15. Nikolsky E, Mehran R, Turcot D et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004; 94: 300-305
16. Solomon R: Nephrology forum: Contrast-medium-induced acute renal failure. Kidney Int 199, 53: 230-242
17. Manske CL, Sprafka JM, Strony JT, Wang Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med, 1990, 89: 615-620
18. Goldenberg I, Matetzky S - Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies, CMAJ, 2005;172:1461-1471
19. Barrett B, Parfrey P, Vavasour HM et al - Contrast nephropathy in patients with impaired renal function: High versus low osmolar media, Kidney Int, 1992, 41: 1274-1279
20. Ahuja TS, Niaz N, Agraharkar M - Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 2000, 54: 11-14
21. Morkos SK, Thomsen SH, Webb JA - Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology. Eur.Radiol. 1999, 9: 1602-1613
22. Toprak O, Cirit M, Yesil M et al - Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol.Dial.Transplant. 2007, 22: 819-826
23. Bartholomew BA, Harjai KJ, Dukkipati S - Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. J.Am.Coll.Cardiol. 2004, 93: 1515-1519
24. Mehran R. et al. - A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Development and initial validation. J.Am.Coll.Cardiol. 2004, 44: 1393-1399
25. Marenzi G, Lauri G, Assanelli E, et al - Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J.Am.Coll.Cardiol. 2004, 44: 1780-1785
26. Solomon R, Werner C, Mann D et al - Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents, N Engl J Med, 1994, 331: 1416-1420
27. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P - Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant. 1998; 13: 358-362
28. Mueller C, Buerkld G, Buettner HJ et al. - Prevention of contrast media-associated nephropathy: Randomized comparison of two hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002, 162: 329-336
29. Dussol B, Morange S, Loundoun A. et al - A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients, Nephrol.Dial. Transplant., 2006, 21: 2120-2126
30. Mueller, Buerkle G, Buettner HJ et al. - Prevention of contrast media-associated nephropathy, Arch.Intern.Med., 2002, 162: 329-336
31. Briguori C, Airoldi F, D'Andrea D et al - Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL). A Randomized Comparison of 3 Preventive Strategies. Circulation 2007, 117: 1211-1217
32. Merten GJ, Burgess VVT, Gray LV et al - Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 2004, 291: 2328-2334
33. Kelly GS - Clinical applications of N-Acetylcysteine. Altern Med Rev 1998, 3: 114-127
34. Drager FL, Andrade L, Barros de Toledo BT et al - Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol.Dial. Transplant. 2004, 19: 1803-1807
35. Marenzi G, Assanelli E, Marana I et al - N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty, N.Engl.J.Med., 2006, 354: 2773-2782
36. Tepel M, van der Giet M, Schwarzfeld C et al - Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N.Engl.J.Med. 2000, 343: 180-184
37. Goldenberg I, Shetcher M, Matetzky S et al - Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. Eur.Heart J. 2004, 25: 212-218
38. Gomes VO, Poli de Figueredo CE, Caramori P et al - N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial, Heart, 2005, 91: 774-778
39. Kshirsagar AV, Poole C, Mottl A, et al - N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials, J.Am.Soc.Nephrot., 2004, 15: 761-769
40. Spargias K, Alexopoulos E, Kyrzopoulos S, et al - Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation, 2004, 110: 2837-2842
41. Stone GW, McCullough PA, Turnlin JA et al - Fenoldopam mesylate for the prevention of contrast-induced nephropathy. A randomized controlled trial, JAMA, 2003, 290: 2284-2291
42. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of lowdose dopaminein high-risk patients undergoing coronary angiography. J Am Coll Cardiol. 1999;34:1682-1688
43. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 1996; 101: 49-53
44. Bagshaw SM, GhaliWA - Theophylline for prevention of contrast-induced nephropathy. A systematic review and. meta-analysis, Arch.Intern.Med., 2005, 165:1087-1093
45. Huber W, Ilgmann K, Page M et al - Effect of theophylline on contrast material-induced nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study, Radiology, 2002, 223: 772-779
46. Kurnick BRC, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast induced nephropathy. Am J Kidney Dis 31: 674-680, 1998
47. Vogt B, Ferrari P, Schoenholzer C, et al - Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111:692-698
48. Marenzi G, Marana I, Lauri G, et al - The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N.Engl.J.Med.2003, 349: 1333-1340.